Live Markets
Tuesday, July 28, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Healthcare

TherapeuticsMD, Inc. (TXMD)

NMS · Drug Manufacturers - Specialty & Generic

$2.06-0.01 (-0.48%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
$23.8M
P/E (TTM)
206.00
EPS
$0.01
Div Yield
52W Range
$0.99–$2.95
Beta
0.59

Company overview

TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally. Its products portfolio includes IMVEXXY for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar and vaginal atrophy due to menopause; BIJUVA to treat moderate-to-severe vasomotor symptoms due to menopause in women with a uterus; and ANNOVERA, a ring-shaped contraceptive vaginal system. The company also offers prescription prenatal vitamin products under the BocaGreenMD and vitaMedMD brand names. It has a license agreement with Mayne Pharma Group Limited. The company sells its products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

Peers in Drug Manufacturers - Specialty & Generic

All in industry →

Recent press releases

April 2026

3 months ago10-K/AHealthcare

TherapeuticsMD, Inc. — 10-K/A Filing

TXMDTherapeuticsMD, Inc.

# 📝 What This Document Is This is an **amended annual report** (Form 10-K/A) for TherapeuticsMD for the year ended December 31, 2025. It's being filed to fix printer errors in the original report. Crucially, it does **not** update any information since the original filing date (March 30, 2026). 👉

Read summaryView on SEC EDGAR

March 2026

4 months ago10-KHealthcare

TherapeuticsMD, Inc. — 10-K Filing

TXMDTherapeuticsMD, Inc.

# 🧾 What This Document Is This is TherapeuticsMD's **annual report (Form 10-K)** for the year ended **December 31, 2025**. It's a mandatory, detailed filing with the SEC that gives a full picture of the company's business, financial condition, risks, and performance for the year. Think of it as the

Read summaryView on SEC EDGAR

SEC filings

All filings →
2 recent filings shown in the timeline above. View all SEC filings →

TherapeuticsMD, Inc. has no reported insider trades in the last 90 days.

Institutional holders

All holders →
As of 2025-12-31 · prior 2025-09-30
1,192,191 sh0.0%
635,222 sh0.0%
397,056 sh+5.4%
350,852 sh+1.9%
96,500 sh+171.8%
209,210 sh0.0%
129,217 sh-1.0%

People at TherapeuticsMD, Inc.

All people →

Quarterly financials

Full financials →
Revenue trend
03/25
$219.0K
NI -$653.0K
06/25
$642.0K
NI $551.0K
09/25
$784.0K
NI $152.0K
RevenueNI = Net Income
EPS trend (diluted)
Latest: $0.01
Prior: $0.05
Revenue sparkline